Angiomyolipoma MRI: Difference between revisions

Jump to navigation Jump to search
No edit summary
No edit summary
Line 12: Line 12:
It is essential to remember that rarely renal cell carcinomas may have macroscopic fat components and as such the presence of fat is strongly indicative of an angiomyolipoma, but not pathognomonic. Since macroscopic fat in RCC almost always occurs in the presence of ossification/calcification, absence of ossification/calcification on imaging is in favour of AML.   
It is essential to remember that rarely renal cell carcinomas may have macroscopic fat components and as such the presence of fat is strongly indicative of an angiomyolipoma, but not pathognomonic. Since macroscopic fat in RCC almost always occurs in the presence of ossification/calcification, absence of ossification/calcification on imaging is in favour of AML.   


[[
[[Image:Angiomyolipoma 101.jpg|thumb|left|350px|MRI: Angiomyolipoma]]
 
Image:Angiomyolipoma 101.jpg|thumb|left|350px|MRI: Angiomyolipoma]]
<br clear="left"/>
<br clear="left"/>



Revision as of 19:06, 21 September 2015

Angiomyolipoma Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Angiomyolipoma from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

Diagnostic Study of Choice

History and Symptoms

Physical Examination

Laboratory Findings

Electrocardiogram

X-ray

CT

MRI

Ultrasound

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Angiomyolipoma MRI On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Angiomyolipoma MRI

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Angiomyolipoma MRI

CDC on Angiomyolipoma MRI

Angiomyolipoma MRI in the news

Blogs on Angiomyolipoma MRI

Directions to Hospitals Treating Angiomyolipoma

Risk calculators and risk factors for Angiomyolipoma MRI

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] Associate Editor-In-Chief: Cafer Zorkun, M.D., Ph.D. [2]

Overview

MRI

MRI is excellent at evaluating fat containing lesions, and two main set of sequences are employed. Firstly, and traditionally if you will, fat saturated techniques demonstrate high signal intensity on non-fat saturated sequences, and loss of signal following fat saturation.

The second method is to use in and out of phase imaging which generates India ink artifact at the interface between fat and non-fat components. This can occur either at the interface between the angiomyolipoma and surrounding kidney or between fat and non-fat components of the mass 8.

It is essential to remember that rarely renal cell carcinomas may have macroscopic fat components and as such the presence of fat is strongly indicative of an angiomyolipoma, but not pathognomonic. Since macroscopic fat in RCC almost always occurs in the presence of ossification/calcification, absence of ossification/calcification on imaging is in favour of AML.

MRI: Angiomyolipoma


MRI: Angiomyolipoma


References


Template:WikiDoc Sources